Friday, December 18, 2020

Neurology/Neuroscience Research Seminar

12:00 PM to 1:00 PM

CME credit available, click HERE

Virtual event

Zoom ID: 910 4550 7427 Passcode: 776945

RNA-protein homeostasis generally refers to the post-transcriptional and post-translational processes that maintain the proper cellular repertoire of functional RNA and proteins. In the cell, RNA exists and functions in a complex with proteins (RNA binding proteins or RBPs) that regulate each step of the RNA life cycle, from transcription to degradation. Central to this regulation is the role of several molecular chaperones that ensure the correct interactions between RNA and proteins, while aiding the biogenesis of large RNA-protein complexes (ribonucleoproteins or RNPs). Many key biochemical reactions take place in specialized subcellular compartments that can be visualized as dots or granules containing RNPs. The composition of these RNP granules is highly dynamic and changes dramatically upon environmental perturbations and stress. This plasticity allows the cell to respond rapidly to changing environments, which is particularly important for neurons that are terminally differentiated and non-dividing. To gain a deeper understanding on how neurons maintain RNA-protein homeostasis, we are investigating the signaling pathways that lead to post-transcriptional modification of RNA and post-translational modifications of RBPs as well as how these modifications regulate the dynamics and function of RNP granules.

Mutations in genes coding for RBPs and molecular chaperones are being reported in a growing list of neurodegenerative diseases, which includes Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA). A remarkable feature of these disease-causing proteins is their ability to transition between different conformational states. However, this ability comes with a cost as many of these proteins have a high propensity to misfold and to aggregate. Indeed, cytoplasmic and nuclear aggregates of RBPs are common molecular hallmarks of a large number of neurodegenerative diseases. An important unresolved question is whether these pathological inclusions are causative agents of neurodegeneration or innocent bystanders. We are addressing this question by investigating how the persistence of RNP aggregates affects RNA-protein homeostasis in motor neurons and what is their relationship to the degeneration of these neurons in ALS.

Enabling these studies, our research employs both cellular and animal models as well as a wide range of biochemical, molecular and cell biological methodologies. A combination of genomic interrogation techniques with high-throughput screenings is also used to identify chemical and genetic modifiers of RNA-protein homeostasis to be developed as therapeutic agents. The long-term implications of our research are twofold. First, this work has the potential of revealing novel regulatory networks that govern fundamental cellular pathways for RNP assembly and clearance. Second, understanding the contribution of altered RNA-protein homeostasis to the pathogenesis of neurodegenerative diseases may lead to new methods of diagnosis and therapy for these devastating disorders.

“RNA-Protein Homeostasis in Healthy and Diseased Neurons”

Francesco Lotti, PhD

Assistant Professor, Department of Pathology & Cell Biology, Columbia University Medical Center